Found: 31
Select item for more details and to access through your institution.
Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- research
Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 877, doi. 10.1002/ajh.26566
- By:
- Publication type:
- Article
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 503, doi. 10.1002/ajh.25758
- By:
- Publication type:
- Article
MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5570, doi. 10.3390/ijms23105570
- By:
- Publication type:
- Article
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e341, doi. 10.1016/j.clml.2023.07.006
- By:
- Publication type:
- Article
Recovery of policlonal immunoglobulins as a predictor factor of increased progression-free survival and overall survival in patients with multiple myeloma ineligible for ASCT.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e176, doi. 10.1016/j.clml.2019.09.295
- By:
- Publication type:
- Article
Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e47, doi. 10.1016/j.clml.2019.09.071
- By:
- Publication type:
- Article
Prognostic Factors in Systemic Light-Chain Amyloidosis with Cardiac Involvement. Single Center Experience at the University Hospital of Salamanca.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S328, doi. 10.1016/j.clml.2019.07.315
- By:
- Publication type:
- Article
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Smoldering Multiple Myeloma: Who and When to Treat.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multiple myeloma with t(11;14): impact of novel agents on outcome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00807-9
- By:
- Publication type:
- Article
Multiple myeloma with t(11;14): impact of novel agents on outcome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00807-9
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
- By:
- Publication type:
- Article
Genetic complexity impacts the clinical outcome of follicular lymphoma patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00395-y
- By:
- Publication type:
- Article
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00377-0
- By:
- Publication type:
- Article
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0283-8
- By:
- Publication type:
- Article
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 7, p. N.PAG, doi. 10.1038/s41408-019-0213-9
- By:
- Publication type:
- Article
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 12, p. 1096, doi. 10.1002/ccr3.706
- By:
- Publication type:
- Article
Targeted therapy and maintenance in myeloma.
- Published in:
- British Medical Bulletin, 2017, v. 122, p. 163, doi. 10.1093/bmb/ldx013
- By:
- Publication type:
- Article
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 278, doi. 10.1111/bjh.18182
- By:
- Publication type:
- Article
Liquid biopsy: a non‐invasive approach for Hodgkin lymphoma genotyping.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 4, p. 542, doi. 10.1111/bjh.17719
- By:
- Publication type:
- Article
Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma.
- Published in:
- Biomedicines, 2024, v. 12, n. 6, p. 1153, doi. 10.3390/biomedicines12061153
- By:
- Publication type:
- Article
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient.
- Published in:
- Biomedicines, 2024, v. 12, n. 1, p. 66, doi. 10.3390/biomedicines12010066
- By:
- Publication type:
- Article
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1689, doi. 10.3390/cancers16091689
- By:
- Publication type:
- Article
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1592, doi. 10.3390/cancers16081592
- By:
- Publication type:
- Article
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1558, doi. 10.3390/cancers15051558
- By:
- Publication type:
- Article
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3615, doi. 10.3390/cancers12123615
- By:
- Publication type:
- Article
RETOS Y AVANCES HACIA LA MEDICINA DE PRECISIÓN EN EL MIELOMA MÚLTIPLE.
- Published in:
- Medicina (Buenos Aires), 2017, v. 77, n. 3, p. 222
- By:
- Publication type:
- Article
Linfocitos T-CAR en pacientes con mieloma múltiple.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2021, v. 45, n. 5, p. 219, doi. 10.7399/fh.11800
- By:
- Publication type:
- Article
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article